Justin Jaffe is the Managing Editor for CNET Money. He has more than 20 years of experience publishing books, articles and research on finance and technology for Wired, IDC and others. He is the ...

Mark Hahn, the Chief Financial Officer of Verona Pharma PLC (NASDAQ:VRNA), executed a significant transaction on August 13, 2024, where the insider sold 400,000 shares of the company. Following ...

A new study finds that mitochondria in our brain cells frequently fling their DNA into the cells' nucleus, where the mitochondrial DNA integrates into chromosomes, possibly causing harm.

Sep. 6, 2024 — Some species of pterosaurs flew by flapping their wings while others soared like vultures, demonstrates a new study. Findings include a new pterosaur with a five-meter wingspan ...

If stored as DNA, every film ever made could be stored in a space smaller than a sugar cube Scientists say they have made a major step forward in efforts to store information as molecules of DNA ...

Adjust the colors to reduce glare and give your eyes a break. Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to ...

Below is Validea's guru fundamental report for VERONA PHARMA PLC - ADR (VRNA). Of the 22 guru strategies we follow, VRNA rates highest using our P/B Growth Investor model based on the published ...

Shares of Verona Pharma VRNA have soared 36.3% since the past month, all thanks to the FDA’s approval of its lead pipeline drug in chronic obstructive pulmonary disease (COPD) indication.

The best way to go about this is with DNA testing kits. These help you learn more about your genetic makeup. The best genetic kits are from Ancestry and 23andMe. The latter was the first to offer ...

View Verona Pharma plc (VRNA) current and estimated P/E ratio data provided by Seeking Alpha.

Mark Hahn, the Chief Financial Officer of Verona Pharma PLC (NASDAQ:VRNA), executed a significant transaction on August 13, 2024, where the insider sold 400,000 shares of the company. Following ...